---
figid: PMC2883240__cmo-2010-015f1
figlink: /pmc/articles/PMC2883240/figure/f1-cmo-2010-015/
number: F1
caption: 'Signaling pathways involving molecular markers for human breast cancer.
  The green lines show cytoplasmic and nuclear membranes. HER2/neu is an orphan receptor
  that can be activated by overexpression or mutation of the transactivating domain
  (rat neu). Overexpression of HER2/neu results in enhanced cell survival and mitogenicity
  and its deregulation can lead to breast tumorigenesis. VEGF shows mitogenic activity
  by stimulating the Ras-Raf-Mapk and PI3K pathways. Erk activation by the Ras-Raf
  pathway leads to activation of the cyclin D1 promoter by Fos/Jun/Ets transcription
  factors. Cyclin D1 makes a complex with Cdk4/6 to phosphorylate Rb and release E2F
  proteins that regulate G1-S transition. Both cyclins E and A2 are direct targets
  for activating E2Fs. Activation of the PI3K-Akt pathway results in enhanced anti-apoptotic
  action through inhibition of the pro-apoptosis proteins (e.g. Bad, GSK3 and the
  transcription factor FKHR-L1, not shown). In addition, activation of the JAK-STAT
  pathway by HER2 leads to cell proliferation. A major mitogenic player acting downstream
  of HER2 is cyclin D1. As indicated, a number of pathways lead from the receptors
  to enhanced activation of cyclin D1, thereby promoting cell cycle progression. Of
  note, cyclin D1 also interacts with the ERα to promote its transcriptional activity
  in Cdk-independent fashion., Dmp1 (cyclin D binding myb-like protein 1; also named
  Dmtf1) is a haplo-insufficient tumor suppressor that regulates the Arf-Mdm2-p53
  tumor surveillance pathway.,, Cyclin D1 is a negative regulator for Dmp1: however,
  it synergizes with Dmp1 on the Arf promoter. BRCA1/2 proteins are directly or indirectly
  phosphorylated by ATM/ATR kinases in response to DNA damage, which interact with
  p53 to stop the cell cycle by activating the p21Cip1/WAF1 promoter.Abbreviations:
  IKK, IκB kinase; Polα, DNA polymerase α; DHFR, dihydrofolate reductase; TK, thymidine
  kinase; TS, thymidylate synthase; PCNA, proliferating cell nuclear antigen; ER,
  estrogen receptor; PR, progesterone receptor; VEGF, vascular endothelial growth
  factor; IR, ionizing radiation; HU, hydroxyurea; ATM, ataxia-telangiectasia mutated;
  ATR, Ataxia telangiectasia and Rad3 related; Chk2, checkpoint homolog 2.'
pmcid: PMC2883240
papertitle: Classical and Novel Prognostic Markers for Breast Cancer and their Clinical
  Significance.
reftext: Pankaj Taneja, et al. Clin Med Insights Oncol. 2010;4:15-34.
pmc_ranked_result_index: '59297'
pathway_score: 0.9609994
filename: cmo-2010-015f1.jpg
figtitle: Signaling pathways involving molecular markers for human breast cancer
year: '2010'
organisms: Homo sapiens
ndex: dbc3cf06-deae-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2883240__cmo-2010-015f1.html
  '@type': Dataset
  description: 'Signaling pathways involving molecular markers for human breast cancer.
    The green lines show cytoplasmic and nuclear membranes. HER2/neu is an orphan
    receptor that can be activated by overexpression or mutation of the transactivating
    domain (rat neu). Overexpression of HER2/neu results in enhanced cell survival
    and mitogenicity and its deregulation can lead to breast tumorigenesis. VEGF shows
    mitogenic activity by stimulating the Ras-Raf-Mapk and PI3K pathways. Erk activation
    by the Ras-Raf pathway leads to activation of the cyclin D1 promoter by Fos/Jun/Ets
    transcription factors. Cyclin D1 makes a complex with Cdk4/6 to phosphorylate
    Rb and release E2F proteins that regulate G1-S transition. Both cyclins E and
    A2 are direct targets for activating E2Fs. Activation of the PI3K-Akt pathway
    results in enhanced anti-apoptotic action through inhibition of the pro-apoptosis
    proteins (e.g. Bad, GSK3 and the transcription factor FKHR-L1, not shown). In
    addition, activation of the JAK-STAT pathway by HER2 leads to cell proliferation.
    A major mitogenic player acting downstream of HER2 is cyclin D1. As indicated,
    a number of pathways lead from the receptors to enhanced activation of cyclin
    D1, thereby promoting cell cycle progression. Of note, cyclin D1 also interacts
    with the ERα to promote its transcriptional activity in Cdk-independent fashion.,
    Dmp1 (cyclin D binding myb-like protein 1; also named Dmtf1) is a haplo-insufficient
    tumor suppressor that regulates the Arf-Mdm2-p53 tumor surveillance pathway.,,
    Cyclin D1 is a negative regulator for Dmp1: however, it synergizes with Dmp1 on
    the Arf promoter. BRCA1/2 proteins are directly or indirectly phosphorylated by
    ATM/ATR kinases in response to DNA damage, which interact with p53 to stop the
    cell cycle by activating the p21Cip1/WAF1 promoter.Abbreviations: IKK, IκB kinase;
    Polα, DNA polymerase α; DHFR, dihydrofolate reductase; TK, thymidine kinase; TS,
    thymidylate synthase; PCNA, proliferating cell nuclear antigen; ER, estrogen receptor;
    PR, progesterone receptor; VEGF, vascular endothelial growth factor; IR, ionizing
    radiation; HU, hydroxyurea; ATM, ataxia-telangiectasia mutated; ATR, Ataxia telangiectasia
    and Rad3 related; Chk2, checkpoint homolog 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDK4
  - BRCA1
  - PIK3R4
  - ATR
  - JAK1
  - PIK3R5
  - AKT1
  - AKT3
  - AKT2
  - JAK3
  - TP53
  - E2F7
  - BRCA2
  - PIK3R6
  - IKBKB
  - PIK3CA
  - CHEK2
  - CCND1
  - PIK3CD
  - DHFR
  - NFKB1
  - CDKN2A
  - ATM
  - CDKN1A
  - ETS1
  - ERBB2
  - VEGFA
  - VEGFB
  - CHUK
  - PIK3CB
  - JAK2
  - MAPK3
  - MDM2
  - MAP2K2
  - POLA1
  - STAT5A
  - TBX2
  - TBX3
  - E2F4
  - PGF
  - E2F5
  - TYK2
  - VEGFC
  - NRAS
  - PCNA
  - DMP1
  - MAP2K1
  - JUN
  - STAT4
  - ARAF
  - E2F1
  - VEGFD
  - E2F3
  - BRAF
  - E2F6
  - E2F8
  - FOS
  - STAT1
  - PIK3CG
  - PIK3R3
  - RAF1
  - E2F2
  - STAT5B
  - STAT6
  - KRAS
  - STAT3
  - HRAS
  - ETS2
  - STAT2
  - MAPK1
  - Breast cancer
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
genes:
- word: Cdk4
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: BRCA1/2
  symbol: BRCA1
  source: hgnc_symbol
  hgnc_symbol: BRCA1
  entrez: '672'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: BRCA1/2
  symbol: BRCA2
  source: hgnc_symbol
  hgnc_symbol: BRCA2
  entrez: '675'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IKK1/IKK2
  symbol: IKK2
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Chk2
  symbol: CHK2
  source: hgnc_alias_symbol
  hgnc_symbol: CHEK2
  entrez: '11200'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: DHFR,TK,TS,PCNA
  symbol: DHFR
  source: hgnc_symbol
  hgnc_symbol: DHFR
  entrez: '1719'
- word: NF-KB/IxB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: p21Cip1
  symbol: p21CIP1
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN1A
  entrez: '1026'
- word: Fos/Jun/Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: HER2/neu
  symbol: NEU
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: HER2/neu
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: IKK1/IKK2
  symbol: IKK1
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Mdm2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: p19Arf
  symbol: p19Arf
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: Pola,
  symbol: POLA
  source: hgnc_prev_symbol
  hgnc_symbol: POLA1
  entrez: '5422'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: Tbx2/3
  symbol: TBX2
  source: hgnc_symbol
  hgnc_symbol: TBX2
  entrez: '6909'
- word: Tbx2/3
  symbol: TBX3
  source: hgnc_symbol
  hgnc_symbol: TBX3
  entrez: '6926'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: Jak
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: DHFR,TK,TS,PCNA
  symbol: PCNA
  source: hgnc_symbol
  hgnc_symbol: PCNA
  entrez: '5111'
- word: Dmp1
  symbol: DMP1
  source: hgnc_symbol
  hgnc_symbol: DMP1
  entrez: '1758'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Fos/Jun/Ets
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: Fos/Jun/Ets
  symbol: FOS
  source: hgnc_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Fos/Jun/Ets
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: Stat
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals: []
diseases:
- word: Breast cancer
  source: ''
  identifier: ''
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2883240__F1
redirect_from: /figures/PMC2883240__F1
figtype: Figure
---
